iPS-derived cardiovascular therapy
Heart Disease/Cardiac Repair
PreclinicalActive
Key Facts
About iHeart Japan
A Japanese biotech developing iPS cell-based regenerative therapies for cardiovascular disease using proprietary differentiation and hydrogel layering technologies.
View full company profile